Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Polydeoxyribonucleotide (Placentrex Integro Mastelli) for Diabetic Foot Ulcers
2007-006754-26Phase 4Completed
- Sponsor
- Mastelli
- Start
- Feb 2008
- Modality
- Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, MicroRNA (miRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Antisense Oligonucleotides (ASOs) → Long RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics
- Countries
- 1
01
Overview
Phase 4, single-arm trial of polideribotide in diabetic foot ulcer (DFU), sponsored by Mastelli. Primary endpoint: Complete wound closure. Started Feb 2008; status: completed.
02
Drugs
polideribotide
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on 2007-006754-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-006754-26.